Research > Neurosciences

Neuroimmunology

Number of publications
123
Publications search

  • Jorge C; Cetó M; Arias A; Blasco E; Gil MP; López R; Dakterzada F; Purroy F; Piñol-Ripoll G

    Level of understanding of Alzheimer disease among caregivers and the general population.

    Neurologia (barcelona, Spain) 36 426-432. .

    [doi:10.1016/j.nrleng.2018.03.004]

  • Meca-Lallana, J; Garcia-Merino, JA; Martinez-Yelamos, S; Vidal-Jordana, A; Costa, L; Eichau, S; Rovira À; Brieva, L; Aguera, E; Zarranz, ARA

    Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies.

    Neurodegenerative Disease Management 11 251-261. .

    [doi:10.2217/nmt-2020-0049]

  • Sanchez-Cazalilla, Marta; Gonzalez-Mingot, Cristina; Torterolo, Giovanni; Torrent, Aurora; Batalla, Iolanda

    Episodic Ataxia Misdiagnosed as Anxiety Disorder.

    The Primary Care Companion For Cns Disorders 23 -. .

    [doi:10.4088/PCC.20l02730]

  • Fernandez-Velasco, JI; Kuhle, J; Monreal, E; Meca-Lallana, V; Meca-Lallana, J; Izquierdo, G; Gascon-Gimenez, F; de la Maza, SS; Walo-Delgado, PE; Maceski, A; Rodriguez-Martin, E; Roldan, E; Villarrubia, N; Saiz, A; Blanco, Y; Sanchez, P; Carreon-Guarnizo, E; Aladro, Y; Brieva, L; Iniguez, C; Gonzalez-Suarez, I; de Antonio, LAR; Masjuan, J; Costa-Frossard, L; Villar, LM

    Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS

    Neurology-Neuroimmunology & Neuroinflammation 8 -. .

    [doi:10.1212/NXI.0000000000000940]

  • Maurino J; Sotoca J; Sempere ÁP; Brieva L; López de Silanes C; Caminero AB; Terzaghi M; Gracia-Gil J; Saposnik G

    High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions.

    Patient-Patient Centered Outcomes Research 14 241-248. .

    [doi:10.1007/s40271-020-00454-3]

  • Purroy F; Vicente-Pascual M; Arque G; Baraldes-Rovira M; Begue R; Gallego Y; Gil MI; Gil-Villar MP; Mauri G; Quilez A; Sanahuja J; Vazquez-Justes D

    Sex-Related Differences in Clinical Features, Neuroimaging, and Long-Term Prognosis After Transient Ischemic Attack.

    STROKE 52 424-433. .

    [doi:10.1161/STROKEAHA.120.032814]

  • Otero-Romero, S; Rodríguez-García, J; Vilella, A; Ara, JR; Brieva, L; Calles, C; Carmona, O; Casanova, V; Costa-Frossard, L; Eichau, S; García-Merino, JA; Garcia-Vidal, C; González-Platas, M; Llaneza, M; Martínez-Ginés, M; Meca-Lallana, JE; Prieto, JM; Rodríguez-Antigüedad, A; Tintoré, M; Blanco, Y; Moral, E

    Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement

    NEUROLOGIA 36 50-60. .

    [doi:10.1016/j.nrl.2020.02.006]

  • Casado V.; Bonaventura I.; Brieva L.; Martínez-Yélamos S.; Martín G.; Presas-Rodriguez S.; Hervas M.; Hernández J.J.; Munteis E.; Escartin A.; Gubieras L.; Mañé-Martínez M.A.; Ramió-Torrentà L.

    Costes directos de los brotes en pacientes con esclerosis múltiple remitente-recurrente

    Neurology Perspectives 1 160-169. .

    [doi:10.1016/j.neurop.2021.05.003]

  • Avila, A; Pastor, P; Planellas, L; Gil-Villar, MP; Hernandez-Vara, J; Fernandez-Dorado, A

    DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia

    REVISTA DE NEUROLOGIA 72 1-8. .

    [doi:10.33588/rn.7201.2020181]

  • Meca-Lallana, J. E.; Fernandez-Prada, M.; Garcia Vazquez, E.; Moreno Guillen, S.; Otero Romero, S.; Rus Hidalgo, M.; Villar Guimerans, L. M.; Eichau Madueño S; Fernandez Fernandez, O.; Izquierdo Ayuso, G.; Álvarez Cermeño JC; Arnal Garcia, C.; Arroyo Gonzalez, R.; Brieva Ruiz, L.; Calles Hernandez, C.; Garcia Merino, A.; Gonzalez Platas, M.; Hernandez Perez, M. A.; Moral Torres, E.; Olascoaga Urtaza, J.; Oliva-Nacarino, P.; Oreja-Guevara, C.; Ortiz Castillo, R.; Oterino, A.; Prieto Gonzalez, J. M.; Ramio-Torrenta, L.; Rodriguez-Antiguedad, A.; Saiz, A.; Tintore, M.; Montalban Gairin, X.

    Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    NEUROLOGIA 37 615-630. .

    [doi:10.1016/j.nrl.2019.11.003]

  • Meca-Lallana, J; Maurino, J; Hernández-Pérez MÁ; Sempere, AP; Brieva, L; García-Arcelay E; Terzaghi, M; Saposnik, G; Ballesteros, J

    Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's Perspective.

    Neurology and Therapy 9 173-179. .

    [doi:10.1007/s40120-020-00176-6]

  • Vazquez-Justes, D; Carreño-Gago L; Garcia-Arum, E; Traveset, A; Montoya, J; Ruiz-Pesini, E; Lopez, R; Brieva, L

    Mitochondrial m.13513G > A Point Mutation in ND5 in a 16-Year-Old Man with Leber Hereditary Optic Neuropathy Detected by Next-Generation Sequencing

    Journal of Pediatric Genetics 8 231-234. .

    [doi:10.1055/s-0039-1691812]